RhumbLine Advisers’s GoHealth GOCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-8,294
| Closed | -$12.5K | – | 4187 |
|
|
2026
Q1 | $12.5K | Sell |
8,294
-870
| -9% | -$1.66K | ﹤0.01% | 3778 |
|
|
2025
Q4 | $19.7K | Buy |
9,164
+2,787
| +44% | +$9.52K | ﹤0.01% | 3764 |
|
|
2025
Q3 | $30.7K | Sell |
6,377
-437
| -6% | -$2.38K | ﹤0.01% | 3727 |
|
|
2025
Q2 | $37.8K | Buy |
6,814
+2,527
| +59% | +$20K | ﹤0.01% | 3714 |
|
|
2025
Q1 | $52.6K | Buy |
4,287
+119
| +3% | +$1.82K | ﹤0.01% | 3563 |
|
|
2024
Q4 | $55.8K | Sell |
4,168
-245
| -6% | -$2.79K | ﹤0.01% | 3628 |
|
|
2024
Q3 | $41.4K | Sell |
4,413
-563
| -11% | -$5.7K | ﹤0.01% | 3714 |
|
|
2024
Q2 | $48.4K | Buy |
4,976
+63
| +1% | +$623 | ﹤0.01% | 3694 |
|
|
2024
Q1 | $51.6K | Sell |
4,913
-684
| -12% | -$8.46K | ﹤0.01% | 3620 |
|
|
2023
Q4 | $74.7K | Sell |
5,597
-186
| -3% | -$2.54K | ﹤0.01% | 3539 |
|
|
2023
Q3 | $83.8K | Buy |
5,783
+253
| +5% | +$4.36K | ﹤0.01% | 3516 |
|
|
2023
Q2 | $109K | Buy |
+5,530
| New | +$86.8K | ﹤0.01% | 3493 |
|
|
2022
Q4 | – | Sell |
-3,178
| Closed | -$17K | – | 3015 |
|
|
2022
Q3 | $17K | Hold |
3,178
| – | – | ﹤0.01% | 3067 |
|
|
2022
Q2 | $29K | Sell |
3,178
-986
| -24% | -$11.5K | ﹤0.01% | 3070 |
|
|
2022
Q1 | $74K | Sell |
4,164
-224
| -5% | -$6.97K | ﹤0.01% | 2938 |
|
|
2021
Q4 | $249K | Buy |
4,388
+29
| +0.7% | +$1.94K | ﹤0.01% | 2767 |
|
|
2021
Q3 | $329K | Buy |
4,359
+1,793
| +70% | +$190K | ﹤0.01% | 2732 |
|
|
2021
Q2 | $432K | Buy |
2,566
+226
| +10% | +$39.6K | ﹤0.01% | 2633 |
|
|
2021
Q1 | $410K | Buy |
2,340
+126
| +6% | +$25.4K | ﹤0.01% | 2576 |
|
|
2020
Q4 | $454K | Buy |
2,214
+116
| +6% | +$21.5K | ﹤0.01% | 2482 |
|
|
2020
Q3 | $410K | Buy |
+2,098
| New | +$505K | ﹤0.01% | 2377 |
|
Other funds holding GOCO
EF
NEWAS
GBT
IA
RhumbLine Advisers's GOCO Position: Q2 2026 in Review
RhumbLine Advisers sold out of GoHealth (GOCO) in Q2 2026, closing a stake of 8,294 shares — an estimated $12.5K sold.
RhumbLine Advisers first reported a position in GOCO in Q3 2020 and held it in 21 quarters. The position peaked at $454K in Q4 2020. 5 funds tracked by Wall St. Rank hold GOCO as of Q2 2026.
- RhumbLine Advisers reported no remaining GoHealth position as of Q2 2026 after selling out during the quarter.
- RhumbLine Advisers sold 8,294 GoHealth shares in Q2 2026, an estimated $12.5K.
- RhumbLine Advisers first reported a position in GoHealth in Q3 2020 and held it in 21 quarters.
- RhumbLine Advisers's GoHealth position peaked at $454K in Q4 2020.
- 5 funds tracked by Wall St. Rank held GoHealth as of Q2 2026.
Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.